Evaluation of Patients With Liver Disease

This observational study aims to better understand different liver diseases, including Hepatitis B, C, and D. Researchers will follow patients with liver disease over time to learn about how these conditions develop, progress, and respond to treatments. You would have an initial check-up as an outpatient, providing blood and urine samples, and having an ultrasound of your liver. After this, you would have yearly check-ups. The study is open to individuals aged 2 to 100 years who have suspected or confirmed acute or chronic liver disease. The main goal is to track how liver disease affects people over time.

Study design
This is an observational study with a planned enrollment of 8050 participants. It is designed to collect samples and data during clinical evaluations and long-term follow-up.
What's involved
You would have an initial outpatient check-up, providing blood and urine samples, and undergoing a liver ultrasound. After the initial visit, you would be asked to follow up once a year for similar check-ups.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed with annual visits to assess predisposition and outcomes related to liver disease susceptibility, progression, and treatment response.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00001971

Evaluation of Patients With Liver Disease

Recruiting
Not specifiedAges 2+Observational
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
~8,050 participants
Updated 2026-08-28 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Predisposition and outcomes related to liver disease susceptibility, progression, and treatment response
Measured over Annual visits
Hepatitis D
Hepatitis C
Hepatitis B
Liver Disease
1 sites across 1 states
Maryland1
  • T. Jake Liang, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Opens a ready-to-send draft in your own email app — review before sending.

  • Predisposition and outcomes related to liver disease susceptibility, progression, and treatment responseAnnual visits

    Predisposition and outcomes related to liver disease susceptibility, progression, and treatment response